CSF2 and influenza: The present study is the first to show that GM-CSF can function as a strong mucosal adjuvant when co-administered to the skin with an influenza DNA vaccine enhancing both the frequency of mucosal antibody detected in the lung and the magnitude, breadth, and function of T cell responses in the lung and gut.